SURMONTIL 25 mg, tablet 50 tablets
Active ingredients: TRIMIPRAMINE (MALÉATE ACIDE DE), Trimipramine
Commercialized according to BDPMDispensing in France: Prescription only
Tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SURMONTIL 25 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 50 comprimé(s)
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1961
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63344192CIP73102296CIP133400931022961Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIMIPRAMINE (MALÉATE ACIDE DE)comprimé | 34,86 mg · un comprimé | SA |
| TRIMIPRAMINE BASEcomprimé | 25 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.